| John D Clark, MSW, LCSW-C | |
|
10905 Fort Washington Rd, Fort Washington, MD 20744-5843 | |
| (301) 292-3994 | |
| (301) 292-4928 |
| Full Name | John D Clark |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 10905 Fort Washington Rd, Fort Washington, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306861331 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 04054 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John D Clark, MSW, LCSW-C 3604 Wabash Ave, Baltimore, MD 21215-7436 Ph: (410) 367-8943 | John D Clark, MSW, LCSW-C 10905 Fort Washington Rd, Fort Washington, MD 20744-5843 Ph: (301) 292-3994 |
News Archive
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research, today (Tuesday).
New tools in the fight against pneumococci - the bugs targeted by vaccines recently announced by the Department of Health - are described by a team led by scientists from the Wellcome Trust Sanger Institute.
CCA Industries, Inc. announced today that it has sold its weight loss business, marketed under the Mega-T brand, to a group formed by Casla Partners Capital Fund I, LP.
Data from the RE-NOVATE® II study presented today at the 15th Annual Congress of the European Hematology Association (EHA) have shown that dabigatran etexilate 220mg once daily is as effective and safe as enoxaparin 40mg in preventing venous thromboembolism (VTE) after total hip replacement surgery.
› Verified 8 days ago
Ms. Veronica Michelle Dillard, DSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8507 Oxon Hill Rd, Fort Washington, MD 20744 Phone: 804-714-9256 Fax: 415-520-6633 | |
Erika Richardson, MSW, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 13211 Coldwater Dr, Fort Washington, MD 20744 Phone: 703-801-0406 | |
Tiana Lewis, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12205 Dillard Pl, Fort Washington, MD 20744 Phone: 202-556-6571 | |
Mrs. Shameka Michele Abney, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 703 Trenary Cir, Fort Washington, MD 20744 Phone: 301-203-1940 | |
Mr. Arnold Harris, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12535 Monterey Cir, Fort Washington, MD 20744 Phone: 240-419-4659 | |
Danette Lawrence, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 12801 Old Fort Rd Ste 303, Fort Washington, MD 20744 Phone: 240-423-4109 |